The supply chain for healthcare products in the United States is tightly linked to global trade. In 2024, many challenges disrupt the steady delivery of medical supplies. Conflicts such as the Israel-Hamas crisis and the war between Russia and Ukraine have caused shipping routes to change and oil prices to go up. This leads to higher transportation costs and longer delivery times. For example, six of the top 10 container shipping companies redirected ships away from the Red Sea. This affects about 62 percent of global shipping capacity. This change makes it harder to get medical supplies on time.
Problems also happen at key global shipping spots like the Panama Canal. Low water levels from long dry spells have lowered the number of ships passing through daily from 36-40 down to 24 since January 2024. Because the Panama Canal handles about 80 percent of global trade, this drop causes long waits and delays for ships carrying important healthcare goods. These delays affect hospitals and clinics in the U.S. trying to keep enough supplies on hand.
Because of these problems, making products inside the U.S. has become more important. It can reduce disruptions and control costs. A 2023 survey by Premier, a group buying organization for healthcare, found that three out of four supply chain leaders say domestic manufacturing is very important for their planning.
Manufacturing CEOs agree. Ninety-six percent are thinking about or starting plans to move production to U.S.-based facilities. This is not just a way to protect against problems but a plan to make supply chains more stable. It reduces dependence on international markets, especially in areas like China and Taiwan. These regions now supply many critical healthcare items like surgical masks, fetal monitors, IV therapy products, gloves, and blood-related products.
However, experts warn that making everything in the U.S. is not realistic. Many raw materials and parts still come from other countries. For example, 80 percent of rare earth materials used to make devices come from abroad. Half of the tungsten for radiation therapy machines is from China. So, foreign suppliers will remain important even if more production moves to the U.S.
The U.S. government has started focusing on supply chain security by creating policies and investing in domestic production. In August 2023, the Biden administration issued an executive order to stop U.S. investments that could help foreign military or surveillance tech, especially in areas like semiconductors and artificial intelligence. These tech sectors overlap with healthcare manufacturing, making supply chain planning more complex.
Several drug companies, including Eli Lilly, Roche, and Novartis, have promised to spend nearly $100 billion over five years on U.S. manufacturing. But experts say it will take time before this spending improves supply stability. The immediate goal is to make sure patients have access to supplies without shortages or price spikes.
Changes in U.S. tariff rules have also caused uncertainty. Drugs are currently not charged tariffs, but proposals could add tariffs on some medical devices and supplies. These higher costs would hit smaller, often rural, healthcare providers the hardest. Many rural hospitals are already financially weak. Up to a third might close if costs rise more. This would hurt patient access.
Industry groups want more openness from manufacturers about where products come from. Right now, many healthcare teams do not know the origin of their supplies. This lack of information makes it harder to predict and prepare for supply problems. A rating system showing supplier reliability could help hospitals choose stable sources instead of just the cheapest ones.
To handle these risks, many healthcare organizations use different strategies. Almost half (45 percent) of U.S. healthcare institutions have set up crisis teams. These teams work on handling supply issues and economic pressures. They renegotiate contracts, find new suppliers, and make backup plans to deal with tariffs and international problems.
Healthcare managers, owners, and IT staff must balance controlling costs with providing good patient care. When products like surgical masks, IV supplies, and blood products run low, providers look for alternate sources and build extra stock when they can. They also try to build strong supplier relationships and work with group purchasing organizations like Premier to get better deals and reduce risks.
Artificial intelligence (AI) and automation tools are becoming more important in dealing with healthcare supply chain challenges. These tools help show supply status clearly, improve decisions, and make office work faster and less error-prone.
AI systems can study large amounts of data about stock levels, delivery times, and supplier quality. They help predict shortages and spot problems early so leaders can change orders on time. For example, AI can warn about delays caused by political conflicts or bad weather by checking real-time shipping information and market changes.
Automation also helps manage order processing, vendor communication, and paperwork. This reduces office work and frees up staff to focus more on patients. For example, automatic alerts can warn about low supplies so teams can act quickly without waiting for manual checks.
Simbo AI, a company that offers AI phone automation and answering service, helps healthcare offices handle supply questions. These systems manage routine calls about order status and delivery updates. This saves staff from repetitive tasks and gets important information to people fast.
Using AI analytics also helps improve how stock is managed. By tracking which supplies are used and how long deliveries take, healthcare providers can keep enough stock without having too much or too little, saving money and space.
Seeing supply chain status in real-time is key to handling disruptions better. AI tools give healthcare providers detailed data at every step of production and delivery. This makes supply chains clearer. When a supplier might have trouble, this early warning lets organizations act faster to find another source or adjust their stock.
Tracking shipments in real-time also helps predict delays caused by international routes. For example, during the Panama Canal restrictions in 2024, AI-based systems could alert healthcare teams early so they could change their ordering plans.
Many healthcare groups still choose suppliers mainly based on price. Adding data on reliability and supplier performance can help them make stronger, smarter purchase choices that avoid risks.
Even though many want to bring manufacturing back to the U.S., healthcare providers know global suppliers are still needed. Some materials, medicines, and parts can only be found abroad or cost less when bought internationally.
Experts say it is not possible to make everything in the U.S. because of high costs, difficulty, and resource needs. Instead, a mixed approach works best. This means supporting U.S. production where it makes sense while keeping strong overseas partnerships.
This way, healthcare providers keep flexible supply chains. They can handle local problems without risking total shortages.
By using these steps, healthcare providers in the United States can better deal with supply chain problems and make sure patients get care without interruption, even in a changing world.
Significant global disruptions continue to impact the healthcare supply chain, including slowdowns in key shipping routes, strained trade relations, and ongoing geopolitical conflicts. These issues lead to uncertainties in product availability, rising costs, and an overall scramble by providers to ensure care continuity.
The conflict adds to global supply chain unease, with potential production stoppages and higher oil prices impacting transportation costs. Shipping routes have been altered, leading to delays in product deliveries.
Extended dry seasons have reduced water levels, causing long queues and delays for ships. The Panama Canal is crucial for global trade, and these restrictions can impede healthcare product shipments.
Increased tensions, particularly involving China and Taiwan, heighten risks for the healthcare supply chain due to the overconcentration of manufacturing critical goods. This leads to potential trade challenges and cost implications.
Providers are rethinking inventory management strategies, diversifying supply sources, and strengthening supplier relationships. They are also leveraging group purchasing organizations to improve resiliency.
Domestic manufacturing is increasingly seen as vital for reducing dependency on global supply. Healthcare leaders emphasize reshoring and seeking domestic suppliers to mitigate risks associated with shipping costs and delays.
According to the 2023 Resiliency survey, three out of four U.S. healthcare supply chain leaders regard domestic manufacturing as an ‘extremely’ or ‘very important’ component of their resiliency strategies.
Premier monitors the global supply chain landscape, offers contingency planning guidance, and provides a weekly product watch list that highlights critical categories at risk for supply chain disruptions.
Reshoring presents an opportunity for healthcare organizations to establish reliable supply sources domestically, reducing vulnerability to international logistics challenges and improving overall supply chain stability.
Examples include surgical masks, fetal monitoring devices, IV therapy products, and blood products. Monitoring these categories helps to prevent clinical disruptions and ensure continuity of care.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
